InvestorsHub Logo
Followers 11
Posts 315
Boards Moderated 0
Alias Born 01/15/2019

Re: None

Sunday, 01/20/2019 10:27:09 AM

Sunday, January 20, 2019 10:27:09 AM

Post# of 163969
Read an article when Steve Rotman, Dr. Allegra, and Dr. Stone first came on board with Vystar and a very interesting read. Here are some of the main points mentioned.

Rotman added, “We will be reviewing potential asset purchases to enhance our balance sheet, and will be aggressively pursuing innovative new higher margin product lines that can increase Vystar revenue. At the same time, we plan to pay off the approximately $3 million in short and long-term debt and payables.”



Steve Rotman brought on Dr Stone as a Board of Director

"Dr. Stone has advised Vystar over the past years relating to product development for the healthcare industry and brings to the board an understanding of the challenges of new product development for start-up companies. He is the Chairman of Medicine at Desert Regional Medical Center in Palm Springs, Calif., and is the Medical Director at multiple DaVita Dialysis Centers. He is also an entrepreneur, serving as the Interim CEO of Fluid Energy Conversion, Inc., a firm specializing in molecular fluid mechanics, specifically high efficiency mass producible energy conversion technologies.




Steve Rotman brought on Dr Allegra as a Board of Director

Dr. Allegra has followed Vystar’s progress for numerous years and has assisted as an investment advisor and investor, providing insight into positioning the company to attract investors, particularly in the healthcare sector. He currently is an Instructor of Epidemiology and Biostatistics at the University of Georgia and an Investment Advisor at Lincoln Lee Investments in Atlanta. Previously he was a Senior Drug Safety Associate at Genentech.



I kept reading the article and saw this from the former Ceo of Vystar:

William Doyle. “I see Vystar’s future in making products with foam and incorporating the retail marketing and advertising approach, which Steve has used with Rotmans very successfully. I will continue to work with Dr. Ranjit Matthan, Vystar Board member and Director of R&D, to further develop new products. I’m excited to be pursuing the development of products to go into other retail markets that we can produce on an OEM basis.



Visited Rotmans Furniture and no wonder it has the reviews it has. The more DD I do the more I like Vystar :)

*red highlights are for new facts I learned from the article
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYST News